InvestorsHub Logo
icon url

biomaven0

09/14/10 10:37 AM

#104171 RE: DewDiligence #104005

MRK’s disingenuous re-definition of null responder



The FDA specifically agrees with you on this in its just-released guidance:

http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM225333.pdf

This should be good for VRTX.

Peter